Patient dies in Pfizer study of Duchenne gene therapy

Patient dies in Pfizer study of Duchenne gene therapy

    08 May 2024

A young boy enrolled in a clinical trial testing an experimental Pfizer gene therapy...

Verve moves forward with backup base editing therapy

Verve moves forward with backup base editing therapy

    08 May 2024

Dive Brief: Verve Therapeutics has treated the first participant in a recently begun clinical...

Bluebird preps for first commercial use of sickle cell gene therapy

Bluebird preps for first commercial use of sickle cell gene therapy

    07 May 2024

Physicians at Children’s National Hospital in Washington, D.C., last week collected the stem cells...

Gossamer sells rights to drug it hopes can rival a new Merck therapy

Gossamer sells rights to drug it hopes can rival a new Merck therapy

    07 May 2024

Gossamer Bio has sold rights to an experimental drug that could rival a new...

BridgeBio spinout launches with $200M for KRAS cancer drugs

BridgeBio spinout launches with $200M for KRAS cancer drugs

    06 May 2024

Dive Brief: A group of well-known biotechnology investors is putting $200 million into a...

Delphia starts up with $67M to make a new type of cancer drug

Delphia starts up with $67M to make a new type of cancer drug

    06 May 2024

Cancer research is always evolving, as scientists search for ways to combat the tricks...

Moderna ends gene editing alliance with Metagenomi

Moderna ends gene editing alliance with Metagenomi

    05 May 2024

Dive Brief: The gene editing company Metagenomi, which went public earlier this year, said...

CG follows big IPO with new results for bladder cancer drug

CG follows big IPO with new results for bladder cancer drug

    05 May 2024

Dive Brief: An experimental drug from CG Oncology has driven bladder cancers into remission...

Why selling to Novartis made sense for Mariana

Why selling to Novartis made sense for Mariana

    04 May 2024

Mariana Oncology arrived at the J.P. Morgan Healthcare Conference this past January with momentum....

Amgen shares soar as executives outline obesity drug push

Amgen shares soar as executives outline obesity drug push

    04 May 2024

Dive Brief: Amgen shares soared by double digits Friday following its announcement an obesity...